Drug intelligence / Profile preview

carbon nanoparticle + methylene blue

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intratumoral, Peritumoral, Intradermal, Subcutaneous, Subareolar, Intralesional
01

Overview

This is a combination of carbon nanoparticles and methylene blue used primarily as tracers or localization agents in surgical oncology, especially for sentinel lymph node (SLN) mapping and localization of nonpalpable breast lesions (NPBLs). Carbon nanoparticles serve as stable dyes that are less likely to diffuse within tissues, allowing for preoperative localization that can be maintained over days. Methylene blue is a readily available dye with rapid metabolism and diffusion properties, making it suitable for intraoperative use but requiring administration shortly before surgery. The combination leverages the stability of carbon nanoparticles with the vivid staining properties of methylene blue to improve accuracy in identifying target tissues during surgery. Both agents have demonstrated safety profiles in clinical use[2][8]. Mechanistically, these agents act as visual tracers rather than exerting pharmacological effects on molecular targets.

Other names
carbon nanoparticles + methylene blueCNS + MBcarbon nanoparticle suspension + methylene blue

Beyond the preview

Go deeper on carbon nanoparticle + methylene blue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbon nanoparticle + methylene blue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call